ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer

Lu, Jianming; Zhong, Chuanfan; Luo, Junqi; Shu, Fangpeng; Lv, Daojun; Liu, Zezhen; Tan, Xiao; Wang, Shuo; Wu, Kaihui; Yang, Taowei; Zhong, Weibo; Wang, Bin; Chen, Yanfei; Li, Yuehan; Jia, Zhenyu; Zou, Yaguang*; Zhong, Weide*; Mao, Xiangming*广州医学院; 南方医科大学; 1
Molecular Therapy-Nucleic Acids2021-12-3DOI: 10.1016/j.omtn.2021.10.006
16被引10阅读
引用收藏
分享

摘要

The circRNAs, a new subclass of non-coding RNAs that are catalyzed by RNA-binding proteins (RBPs), have been reported to be associated with the progression of multiple types of cancer. We previously discovered that heterogeneous nuclear ribonucleoprotein L (HnRNP-L), a multi-functional RBP, is associated with pro-proliferation and anti-apoptosis activities in prostate tumor cells. In this study, we aim to establish the biological relevance of circCSPP1 (a newly discovered signature circRNA in prostate cancer [PCa]) and HnRNP-L to prostate cancer progression. First, we demonstrated that circCSPP1 expression was higher in prostate cancer tissues than in benign tissues and higher in prostate cancer cells than in benign cells. Then, the in vitro gainand loss-of-function experiments showed that the circCSPP1 expression in prostate cancer cells was regulated by HnRNP-L, and the increased circCSPP1 significantly induced autophagy, which led to an enhanced potential in proliferation, migration, and invasion of prostate cancer cells. These results were consistent with the in vivo experiment where increased or decreased circCSPP1 was associated with higher or slower growth rate in grafted tumors. Finally, we demonstrated the potential competing endogenous RNA network, involving circCSPP1, miR-520h, and early growth response factor 1 (EGR1), in prostate cancer cells, which may play an important role in prostate cancer progression. Our study indicated that the increase in circCSPP1 in prostate cancer, which may be catalyzed by HnRNP-L, can induce cellular autophagy through the circCSPP1-miR-520h-EGR1 axis, leading to the progression of prostate tumor. This newly discovered circRNA biomarker may be used for clinical prognosis of prostate cancer as well as for development of novel therapy plans.

学科与关键词

关键词
NONCODING RNACIRCULAR RNAINVASION
相关
加载中…
  • Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress malignant characteristics and promote apoptosis in prostate cancer cells
    Han, Yuefu; Wen, Xingqiao*; Li, Xiaojuan; Chen, Dong; Peng, Lian; Lai, Bin; Huang, HongcaiBioengineered, 2021, 12(1): 5620-5631.被引 7
  • Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis
    Chen, Wenbin; Cen, Shengren; Zhou, Xumin; Yang, Taowei; Wu, Kaihui; Zou, Libin; Luo, Junqi; Li, Chuanyin*; Lv, Daojun*; Mao, Xiangming*Frontiers in Cell and Developmental Biology, 2021, 8: 624764.被引 38
  • Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
    Yu, Yu-Zhong; Lv, Dao-Jun; Wang, Chong; Song, Xian-Lu; Xie, Tao; Wang, Tao; Li, Zhi-Min; Guo, Jia-Ding; Fu, Du-Jiang; Li, Kang-Jin; Wu, Ding-Lan; Chan, Franky Leung; Feng, Ning-Han*; Chen, Zhe-Sheng*; Zhao, Shan-Chao*Molecular Cancer, 2022, 21(1): 12.被引 57
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Therapy-Nucleic Acids
发表日期
2021-12-03
卷期
第 26 卷
页码
927-944
DOI
10.1016/j.omtn.2021.10.006
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Sci-ence Foundation of China [81773277, 82003271, 82072813, 82173039]; China Postdoctoral Science Foundation [2019M 662979, 2018M643126, 2019M662865]; Guangzhou Science and Technology Project [201803010014, 201803040001]; Guang-dong Basic and Applied Basic Research Foundation [2019A 1515110033, 2021A1515010659]; Guangdong Medical Science Research Project [A2020544]

作者

  • L

    Lu, Jianming (第一作者)

    southern med univ

  • Z

    Zhong, Chuanfan

    southern med univ

查看全部 18 位作者收起作者
  • L

    Luo, Junqi

    southern med univ

  • S

    Shu, Fangpeng

    southern med univ

  • L

    Lv, Daojun

    1 · guangzhou med univ

  • L

    Liu, Zezhen

    1 · guangzhou med univ

  • T

    Tan, Xiao

  • W

    Wang, Shuo

    southern med univ

  • W

    Wu, Kaihui

    southern med univ

  • Y

    Yang, Taowei

    southern med univ

  • Z

    Zhong, Weibo

    southern med univ

  • W

    Wang, Bin

    guangzhou med univ

  • C

    Chen, Yanfei

    guangzhou med univ

  • L

    Li, Yuehan

  • J

    Jia, Zhenyu

  • Z

    Zou, Yaguang (通讯)

    southern med univ

  • Z

    Zhong, Weide (通讯)

    southern med univ

  • M

    Mao, Xiangming (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417